TY  - GEN
AU  - Garcia-Pavia, Pablo
AU  - Oręziak, Artur
AU  - Masri, Ahmad
AU  - Barriales-Villa, Roberto
AU  - Abraham, Theodore P
AU  - Owens, Anjali T
AU  - Jensen, Morten K
AU  - Wojakowski, Wojciech
AU  - Seidler, Tim
AU  - Hagege, Albert
AU  - Lakdawala, Neal K
AU  - Wang, Andrew
AU  - Wheeler, Matthew T
AU  - Choudhury, Lubna
AU  - Balaratnam, Ganesh
AU  - Shah, Ashish
AU  - Fox, Shawna
AU  - Hegde, Sheila M
AU  - Olivotto, Iacopo
PY  - 2024
UR  - https://hdl.handle.net/20.500.12105/27282
AB  - Long-term safety and efficacy of mavacamten in patients with obstructive hypertrophic cardiomyopathy (HCM) are unknown. MAVA-LTE (NCT03723655) is an ongoing, 5-year, open-label extension study designed to evaluate the long-term effects of mavacamten....
LA  - eng
KW  - Efficacy
KW  - Long-term outcomes
KW  - MAVA-LTE (EXPLORER cohort)
KW  - Mavacamten
KW  - Obstructive hypertrophic cardiomyopathy
KW  - Safety
TI  - Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy.
TY  - research article
ER  -